Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 6, 1996

View Archived Issues

New analgesic compounds with novel mechanism of action disclosed by Novo Nordisk

Anti-E-selectin antisense compound from Isis inhibits mRNA splicing

ChemGenics/Wyeth-Ayerst antibacterial drug discovery collaboration

Cytovene approved for new indication in U.S.

Connective Therapeutics acquires rheumatoid arthritis Rx from SKB

PAI-1 diagnostic approved for marketing in U.S.

Successful pivotal Mexican trial for oral impotency therapy

Varian, University of Arizona collaborate on methods of enhancing gene therapy efficacy

FDA tentatively approves generic NSAID

SKB, IDEC initiate phase III testing of antirheumatic antibody

Oncogene Science issued patent on gene transcription

Cytel to implement new development strategy for HBV vaccine

Etex signs marketing agreement for bone substitute

Sepracor gets go-ahead for U.S. clinical trials on (S)-oxybutynin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...